Topically applied heparins for the treatment of vascular disorders: A comprehensive review

Clinical Drug Investigation

Volumn 28, Issue 10, 2008, Pages 603-614

  Vecchio, Cesare ^a,c   Frisinghelli, Anna ^b  

^a UO Medicina Riabilitativa a Indirizzo Vascolare   (Italy)

^b Garbagnate Milanese   (Italy)

^c AO G Salvini   (Italy)

Author keywords

Antithrombotics, therapeutic use; Heparin, therapeutic use; Peripheral vascular disorders; Thrombophlebitis; Topical; Venous insufficiency

Indexed keywords

CORTICOSTEROID; ENOXAPARIN; ESCIN; FLUOCINOLONE ACETONIDE; GLYCOSAMINOGLYCAN POLYSULFATE; HEPARIN; HEPARINOID; HIRUDOID; LIOTON; LIPOHEP FORTE; LIPOSOME; LOW MOLECULAR WEIGHT HEPARIN; MOVELAT; PHOSPHOLIPID; PIROXICAM; PLACEBO; SALICYLIC ACID; UNCLASSIFIED DRUG;

BLOOD CLOTTING; CLINICAL FEATURE; CREAM; DEEP VEIN THROMBOSIS; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; EDEMA; ERYTHEMA; GEL; HUMAN; HYPODERMA; MICROANGIOPATHY; MICROCIRCULATION; OINTMENT; PAIN; PHLEBITIS; PRIORITY JOURNAL; REVIEW; SCLEROTHERAPY; SIDE EFFECT; SINGLE DRUG DOSE; SKIN INFLAMMATION; SUPERFICIAL THROMBOPHLEBITIS; TREATMENT DURATION; TREATMENT OUTCOME; URTICARIA; VASCULAR DISEASE; VEIN INSUFFICIENCY;

ADMINISTRATION, TOPICAL; ANTICOAGULANTS; CLINICAL TRIALS AS TOPIC; HEPARIN; HUMANS; THROMBOPHLEBITIS; TREATMENT OUTCOME; VENOUS INSUFFICIENCY;

EID: 51649102765     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200828100-00001     Document Type: Review

References (39)

1. Green D. Coagulation cascade. Hemodial Int 2006; 10 Suppl. 2: S2-4
2. Segal JB, Streiff MB, Hofmann LV, et al. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med 2007 Feb 6; 146 (3): 211-22
3. Eikelboom JW, Anand SS, Malmberg K, et al. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet 2000 Jun 3; 355 (9219): 1936-42
4. Klein AL, Jasper SE, Katz WE, et al. The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: Assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study. Eur Heart J 2006 Dec; 27 (23): 2858-65
5. Leonardi MJ, McGory ML, Ko CY. The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg 2006; 141 (8): 790-7
6. de Moerloose P, Gavillet O, Salomon D, et al. Heparin-related activity in peripheral venous blood after percutaneous application of various glycosaminoglycan containing creams. Blood Coagul Fibrinolysis 1992 Dec; 3 (6): 827-8
7. Katakkar SB. Use of heparin as a topical antithrombotic and anti-inflammatory agent. J Natl Cancer Inst 1993; 85 (22): 1865-6
8. Pola P, Tondi P, Flore R, et al. Trend of blood and plasma viscosity and serum lipids following topical treatment with heparin sodium [Italian]. G Ital Angiologia 1984, 4 (3): 135-8
9. Milio G, Feerara R, Cospite M. Use of heparin sodium in the form of a gel in nervous disorders of the lower limb marked by inflammation. Acta Cardiol Mediterranea 1985; 3 (1): 283-8
10. Cappelli R. Treatment of lower limb vascular disorders with a gel containing heparin sodium. Farmaci 1984; 9 (85): 163-7
11. Marrapodi E, Bocci L, Cipriani C, et al. The usefulness of percutaneous heparin management in phlebological therapy [Italian]. G Ital Angiologia 1986; 6 (2): 115-22
12. Navratilova Z, Semradova V. Local application of heparin: possibility of its use in phlebology [in Czech]. Cesk Dermatol 2000; 75 (5): 230-2
13. Virgilio V, Cavallaro S. Clinical evaluation of a gel containing heparin sodium in the management of venous diseases of the lower limbs. Ricerca Medica 1985, 11
14. Wojcicki J, Samochowiec L, Lawczyski L, et al. Local treatment of thrombophlebitis with Essaven gel. Arch Immunol Ther Exp 1976; 24 (6): 807-10
15. Vilardell M, Sabat D, Arnaiz JA, et al. Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter: a double-blind, randomized, placebo-controlled trial. Eur J Clin Pharmacol 1999 Feb; 54 (12): 917-21
16. Mehta PP, Sagar S, Kakkar VV. Treatment of superficial thrombophlebitis: a randomized, double-blind trial of heparinoid cream. BMJ 1975 Sep 13; 3 (5984): 614-6
17. Schedel F, Hennemann B, Reindl P. Controlled study on the efficacy of external treatment in surface-near thrombophlebitis [in German]. Fortschr Med 1977 Jun 16; 95 (23): 1557-60
18. Neto HJG, Hueb WC. Clinical efficacy and tolerability evaluation of Hirudoid post-sclerotherapy of microvarices and telangiectasis of lower limbs [in Portuguese]. Rev Brasil Med 2001; 58 (9): 665-70
19. Bergqvist D, Brunkwall J, Jensen N, et al. Treatment of superficial thrombophlebitis: a comparative trial between placebo, Hirudoid cream and piroxicam gel. Ann Chir Gynaecol 1990; 79 (2): 92-6
20. De Angelis CP, De Nicola P, Bianco G, et al. Clinical evaluation of the effectiveness and tolerance of heparin as a topical therapy in vascular diseases [in Italian]. Antolog Med Italiana 1985; 5: 524-7
21. D'Amico N, Greco N, Ruotolo G. A clinical contribution to pharmacology in venous pathology and its complications: effects of heparin in the form of a gel [in Italian]. Minerva Cardioangiol 1987; 35: 195-203
22. Inga C, Pignocchino P, Casini A, et al. Clinical evaluation of a gel with a high heparin content [in Italian]. Minerva Angiolog 1985; 10 (3): 247-9
23. Górski G, Szopiński P, Michalak J, et al. Liposomal heparin spray: a new formula in adjunctive treatment of superficial venous thrombosis. Angiology 2005; 56 (1): 9-17
24. Subrahmanyam M. Topical effect of heparin and a corticosteroid in prevention of infusion thrombophlebitis. Indian J Physiol Pharmacol 1988 Jul-Sep; 32 (3): 223-5
25. Woodhouse CR. Movelat in the prophylaxis of infusion thrombophlebitis. BMJ 1979 Feb 17; 1 (6161): 454-5
26. Sukharev, II, Vlakov GG. The treatment of acute and chronic venous insufficiency of the lower extremities by using Lioton-1000 gel [Russian]. Klinicheskaia Khirurgiia 1999 (6): 5-6
27. Novosad EM. Lioton-1000 gel in the prevention of thrombosis of the major veins of the extremities [Russian]. Likarska Sprava 1999 Jan-Feb (1): 122-4
28. Daróczy J. Trial of effectivity of Lioton® 100.000 gel in lower limb varicosity syndrome [in Hungarian]. Érbetegségek, IX, évfolyam 3, 2002/3: 85-90
29. Cesarone MR, De Sanctis MT, Incandela L, et al. Microvascular changes in venous hypertension due to varicose veins after standardized application of Essaven gel: a placebo-controlled, randomized study. Angiology 2001 Dec; 52 Suppl. 3: S11-6
30. Incandela L, Belcaro G, Cesarone MR, et al. Changes in microcirculation in venous ulcers with Essaven gel: a pilot, cross-over, placebo-controlled, randomized study. Angiology 2001 Dec; 52 Suppl. 3: S23-7
31. Incandela L, Belcaro G, Cesarone MR, et al. Microangiopathy and venous ulceration: topical treatment with Essaven gel. A placebo-controlled, randomized study. Angiology 2001 Dec; 52 Suppl. 3: S17-21
32. De Sanctis MT, Incandela L, Belcaro G, et al. Topical treatment of venous microangiopathy in patients with venous ulceration with Essaven gel: a placebo-controlled, randomized study. Angiology 2001 Dec; 52 Suppl. 3: S29-34
33. Incandela L, Belcaro G, Cesarone MR, et al. Microvascular alterations in diabetic microangiopathy: topical treatment with Essaven gel. A placebo-controlled, randomized study. Angiology 2001 Dec; 52 Suppl. 3: S35-41
34. De Sanctis MT, Cesarone MR, Incandela L, et al. Four-week treatment with Essaven gel in diabetic microangiopathy: a placebo-controlled, randomized study. Angiology 2001 Dec; 52 Suppl. 3: S49-55
35. De Sanctis MT, Cesarone MR, Incandela L, et al. Treatment of superficial vein thrombosis with standardized application of Essaven gel: a placebo-controlled, randomized study. Angiology 2001 Dec; 52 Suppl. 3: S57-62
36. Cesarone MR, Incandela L, Belcaro G, et al. Two-week topical treatment with Essaven gel in patients with diabetic microangiopathy: a placebo-controlled, randomized study. Angiology 2001 Dec; 52 Suppl. 3: S43-8
37. Wichers IM, Di Nisio M, Buller HR, et al. Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Haematologica 2005 May; 90 (5): 672-7
38. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev 2007; 2: CD0044982
39. Incandela L, De Sanctis MT, Cesarone MR, et al. Treatment of superficial vein thrombosis: clinical evaluation of Essaven gel. A placebo-controlled, 8-week, randomized study. Angiology 2001 Dec; 52 Suppl. 3: S69-72